MedMira Inc MMIRF

Primary Symbol: V.MIR

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc > waiting for promised JANUARY UPDATES

<< Previous

Bullboard Posts

Next >>

Comment by mrmarket1on Jan 29, 2023 7:17pm

147 Views

Post# 35253132

RE:waiting for promised JANUARY UPDATES

Halifax, Nova Scotia, 29 December, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) presents its latest addition to the VYRATMproduct line, the VYRATM TriDemic Antigen Rapid Test for the simultaneous detection of SARS-CoV-2, Flu A, Flu B and Respiratory Syncytial Virus (RSV). VYRA TriDemic, a four-in-one test, which is a direct response to the rise of RSV cases globally.

The management is confident to complete this within a short time frame due to size of samples required and the highly experienced clinical partner engaged for this step. MedMira will provide further regulatory updates on the progress in January 2023

https://www.medmira.info/post/medmira-introduces-vyra-tridemic

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost